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Abstract
Background: Diagnostic tests for dry eye disease (DED), including ocular surface disease index (OSDI), tear breakup
time (TBUT), corneal fluorescein staining, and lissamine staining, have great deal of variability. We investigated
whether fluorophotometry correlated with previously established DED diagnostic tests and whether it could serve
as a novel objective metric to evaluate DED.
Methods: Dry eye patients who have had established signs or symptoms for at least 6 months were included in
this observational study. Normal subjects with no symptoms of dry eyes served as controls. Each eye had a baseline
fluorescein scan prior to any fluorescein dye. Fluorescein dye was then placed into both eyes, rinsed with
saline solution, and scanned at 5, 10, 15, and 30 min. Patients were administered the following diagnostic
tests to correlate with fluorophotometry: OSDI, TBUT, fluorescein, and lissamine. Standard protocols were used.
P < 0.05 was considered significant.
Results: Fifty eyes from 25 patients (DED = 22 eyes, 11 patients; Normal = 28 eyes, 14 patients) were included.
Baseline scans of the dry eye and control groups did not show any statistical difference (p = 0.84). Fluorescein
concentration of DED and normal patients showed statistical significance at all time intervals (p < 10−5, 0.001,
0.002, 0.049 for 5, 10, 15, & 30 min respectively). Fluorophotometry values converged towards baseline as time
elapsed, but both groups were still statistically different at 30 min (p < 0.01). We used four fluorophotometry
scoring methods and correlated them with OSDI, TBUT, fluorescein, and lissamine along with adjusted and
aggregate scores. The four scoring schemes did not show any significant correlations with the other tests,
except for correlations seen with lissamine and 10 (p = 0.045, 0.034) and 15 min (p = 0.013, 0.012), and with
aggregate scores and 15 min (p = 0.042, 0.017).
Conclusions: Fluorophotometry generally did not correlate with any other DED tests, even though it showed
capability of differentiating between DED and normal eyes up to 30 min after fluorescein dye instillation.
There may be an aspect of DED that is missed in the current regimen of DED tests and only captured with
fluorophotometry. Adding fluorophotometry may be useful in screening, diagnosing, and monitoring patients
with DED.
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Background
Keratoconjunctivitis sicca or dry eye disease (DED) is one
of the most common ocular conditions that patients seek
care for and affects as many as 11.4 % of men and 16.7 %
of women [1]. Current treatment options range from arti-
ficial tears to anti-inflammatory and immunosuppressant
agents, and treatment has shown to drastically improve
quality of life and prevent damage to the ocular surface
[2]. The most common methods to diagnose DED include
a comprehensive eye exam, symptom survey with Ocular
Surface Disease Index (OSDI), tear breakup time (TBUT),
lissamine green staining (lissamine), Schirmer’s, and cor-
neal fluorescein staining (fluorescein), but these diagnostic
tests have a great deal of variability and potential for bias,
making objective and accurate DED diagnosis and man-
agement difficult [3].
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Miyata et al. suggested that a fluorophotometer could
measure corneal epithelial permeability due to the correl-
ation between fluorescein concentrations in the cornea
and corneal damage [4]. Specifically, fluorophotometry
could evaluate ocular surface epithelium barrier function
[5]. Although some degree of corneal staining is inevitable
and found on 79 % of corneas, the majority of the dye
should remain in the tear film on the surface of the eye
and not adhere to the eyes as the corneal epithelium pro-
tects the underlying layers of the cornea under normal
conditions [6, 7].
Using the Fluorotron Master fluorophotometer (Ocu-
metrics, Mountain View, CA), we showed in our previ-
ous study that differentiating between DED and normal
patients depending on the fluorescein concentration in
the cornea at certain time intervals was possible [8].
This study aims to test the capability of the fluorophot-
ometer further: we investigated whether fluorophoto-
metry correlated with already established diagnostic
tests for dry eye disease and whether it could serve as a
minimally invasive objective metric to evaluate dry eye
disease.
Methods
After receiving approval from Icahn School of Medicine
at Mount Sinai’s Institutional Review Board, prospective
patients were recruited for this observational study.
Informed consent was obtained from all subjects. The
study was carried out with patients who visited the
Faculty Practice of Department of Ophthalmology at Icahn
School of Medicine at Mount Sinai in New York, NY.
Data were collected from normal and dry eye pa-
tients, who were followed for DED by an ophthalmolo-
gist prior to the study for 6 months or more. Patients
were classified as normal or DED according to their
clinical diagnosis. DED patients must have had at least
2 signs and/or symptoms of dry eyes such as foreign
body sensation, ocular irritation, light sensitivity, burn-
ing and grittiness, itchiness, edema of lid, conjunctiva
and cornea, or hyperemia in order to be included in the
study. Normal subjects who had no signs or symptoms
of dry eyes or other ocular problems except for refractive
error served as controls. Patients with any conditions that
limited their ability to understand the consent were ex-
cluded from the study. Pregnant patients, those under
18 years of age, patients with acute or sub-acute inflam-
mation/infection of the anterior segment of the eye, and
those with history of allergy to fluorescein were also ex-
cluded from the study.
All fluorophotometry of the cornea was performed with
the Fluorotron Master flurophotometer (Ocumetrics,
Mountain View, CA) in accordance to the manufacturer’s
instructions and the provided scanning software. Each eye
had a baseline fluorescein scan performed prior to any
introduction of fluorescein dye to measure each eye’s
intrinsic fluorescence. 50 μl of 1 % sodium fluorescein dye
was then placed into both eyes. Two minutes later, the
fluorescein was thoroughly rinsed with 100 μl of non-
preserved normal balanced saline solution. Fluorescein
scans were started immediately after washing and re-
corded at 5, 10, 15, and 30 min thereafter, beginning with
the OD eye. The fluorescein scan involved no direct
contact between the eye and the device. The corneal peak
values of fluorescein concentration were recorded. The
following diagnostic tests were also administered to
patients with DED to correlate with fluorophotometry
results: OSDI, TBUT, fluorescein, and lissamine. Standard
protocols were used for the DED diagnostic exams. TBUT
was observed under cobalt blue illumination, once per
eye. We used the National Eye Institute scale for grading
fluorescein corneal staining and the Van Bijsterveld scale
for grading lissamine green staining of the conjunctiva.
Corneal fluorescein levels at multiple time points in
both eyes were recorded into Microsoft Excel (Microsoft,
Redmond, Washington). Spearman’s correlations were
used to detect any correlations between fluorophoto-
metry and other DED diagnostic tests. Microsoft Excel
and SPSS version 20.0 (SPSS Inc., Chicago, IL) were
used for statistical analysis. P < 0.05 (two-tailed) was
considered significant.
Results
We included 50 eyes from 25 patients (DED = 22 eyes,
11 patients; Normal = 28 eyes, 14 patients). Baseline
scans of the dry eye (22.19 ± 8.05 ng/ml) and control
(21.81 ± 5.17 ng/ml) did not show any statistical differ-
ence (p = 0.84). Figure 1 shows the amount of increase
in fluorescein concentration relative to baseline at mul-
tiple time intervals (5, 10, 15, and 30 min). Fluorescein
concentration of DED and control groups showed statis-
tical significance at all time intervals (p < 10−5, 0.001,
0.002, 0.049 for 5, 10, 15, & 30 min, respectively). DED al-
ways had higher fluorescein concentrations than controls.
Fluorescein concentrations in both groups converged to-
wards their baseline as time elapsed, but were still statisti-
cally different from their baseline at 30 min (p < 0.01).
Fluorophotometry values in DED group were catego-
rized into 4 major schemes, which most clearly illustrated
the change in fluorophotometry values: 1) increases in
fluorescein concentration relative to its baseline at mul-
tiple time intervals (5, 10, 15, and 30 min) were labeled as
‘DIFF X’ where X represented the minutes. For instance,
DIFF 10 was defined as the fluorescein concentration
10 min after washout of fluorescein dye minus the base-
line fluorescein concentration of that patient. 2) log values
of ‘DIFF X’ were taken and labeled as ‘LOGDIFF X.’ 3)
similar to the ‘DIFF X’ scoring, percent changes in fluores-
cein concentration relative to its baseline at multiple time
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intervals (5, 10, 15, and 30 min) were labeled as ‘PERC X’
where X represented the minutes. 4) log values of ‘PERC
X’ were taken and labeled as ‘LOGPERC X’.
To determine how fluorophotometry reflected the re-
sults of other DED diagnostic methods, we correlated
the four fluorophotometry scoring schemes with OSDI,
TBUT, fluorescein, and lissamine (Table 1). OSDI scores
were adjusted into quartiles (0–25 = score of 1, 26–50 =
score of 2, 51–75 = score of 3, 76–100 = score of 4)
named ‘OSDI Quartiles’ to create a score that was more
similar to scores of other tests. The double-digit OSDI
scores were adjusted to fit with the single digit scores
of other diagnostic tests. Using this, we created an
aggregate score that added OSDI Quartiles, TBUT,
Fluorescein, and Lissamine (Aggregate score = OSDI
Quartile + TBUT + fluorescein + lissamine).
After correlation to other DED diagnostic tests, the
four fluorophotometry scoring schemes generally did
not show any significant correlations with OSDI, OSDI
Quartiles, TBUT, fluorescein, and lissamine tests. Signifi-
cant correlations were seen with lissamine scores and
LOGDIFF 10 (p = 0.045), LOGDIFF 15 (p = 0.013), LOG-
PERC 10 (p = 0.034), and LOGPERC 15 (p = 0.012) and
with aggregate scores and LOGDIFF 15 (p = 0.042) and
LOGPERC 15 (p = 0.017).
Discussion
DED affects a significant number of people, with preva-
lence ranging from 7 % in the United States to 33 % in
Taiwan and Japan, but DED is difficult to diagnose and
no clear gold standard to evaluate DED exists [9, 10].
Clinicians often rely on multitude of tests, including
symptoms or signs and a battery of diagnostic tests, in-
cluding TBUT, fluorescein, and lissamine. We strove to
determine if fluorophotometry could fill that void
through correlation with other established tests and bet-
ter classify DED according to severity.
Past studies by Kinoshita et al. and Yokoi have found
that the fluorophotometer could evaluate ocular surface
epithelium barrier function using a similar methodology
to our study [5, 11–13]. In one of their studies, they
showed that in accordance with severity, fluorescein up-
take in dry eye patients showed significant increase, and
that with treatment with hyaluronan eye drops, there
was significant barrier function improvement after
2 weeks [12, 13]. In our study, we evaluated not only
fluorophotometry’s ability to differentiate between dry
eye and normal eyes, but also the correlations of its
results with different diagnostic techniques of dry eye.
Among the multitude of tests available, we aimed to in-
vestigate whether fluorophotometry could outperform
any diagnostic tests, combine 2–3 diagnostic tests, or
become another test that measures an aspect of dry eye
that is not yet captured by any of the diagnostic tests
for DED.
Consistent with our previous study, this study showed
that fluorophotometry could differentiate between DED
and normal eyes up to 30 min post fluorescein dye
instillation [8]. However, except for minor correlations
with lissamine and aggregate scores at 10 and 15 min,
fluorophotometry in our current study did not show any
significant correlations with other DED diagnostic tests,
such as OSDI, TBUT, fluorescein, and lissamine. These
differences could arise because fluorophotometry en-
compasses a larger view of DED, taking into account the
overall increased permeability of the cornea in ocular
surface disease patients rather than focusing on one as-
pect of DED. For instance, TBUT takes into account tear
production and evaporation, but fluorophotometry in-
cludes all factors that damage the corneal epithelium,
and utilizes tear break up as only one component of
many factors that contribute to DED.
Another possible function for fluorophotometry is to
measure aspects of DED not captured by other diagnostic
tests, which are somewhat imperfect themselves and thus
contribute to the difficulty of objectively diagnosing DED.
Dry eye patients have ocular surface disease that increase
corneal permeability to fluorescein, but the amount of
change as we measured it did not correlate with other
tests. Fluorophotometry may include a component not yet
detected with current diagnostic tests and thus could be
done to rule out DED when DED is suspected, but other
diagnostic tests are normal. Due to its unique position
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Fig. 1 Average fluorescein concentration in dry eye patients. Legend:
Fig. 1 depicts the increase in corneal peak fluorescein concentrations
(ng/ml) from baseline at 5, 10, 15, and 30 min time intervals for dry eye
disease and normal patients. The top line with diamond markers
represents dry eye disease patients, and the bottom line with square
markers represents normal patients. Error bars represent the 95 %
confidence interval. Fluorescein concentrations converged towards its
baseline as time elapsed, but were still statistically different from its
baseline at 30 min (p < 0.01)
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its basic tests when evaluating DED may aid in diagnosing
DED or in research settings studying DED. Continued re-
search in this area could clarify this mismatch.
Fluorophotometry also did not correlate with clinical
symptoms as measured by OSDI. Although there is some
evidence showing OSDI can measure the severity of dry
eye, the non-correlation was unsurprising since DED signs
and symptoms are poorly correlated, compounded by
variability between seasons, time of day, and findings
among eye examinations, suggesting that symptoms
may not truly reflect the whole dry eye state in patients
[14, 15]. Though the cornea may be damaged, patients
may still be asymptomatic. One possible explanation is
that with damage to the ocular surface, the central cor-
nea sensitivity decreases, making the patient less symp-
tomatic [14, 16]. Similarly, the cornea may be healthy
Table 1 Comparison of four fluorophotometry scoring schemes with other dry eye diagnostic tests
OSDI OSDI Quartiles TBUT Fluorescein Lissamine Aggregate score
DIFF5 Correlation Coefficient .172 .056 .213 −.086 −.075 .030
Significance .444 .805 .340 .703 .739 .895
DIFF10 Correlation Coefficient .118 −.030 .050 −.163 −.274 −.186
Significance .602 .895 .826 .468 .216 .408
DIFF15 Correlation Coefficient .093 −.046 −.031 −.174 −.357 −.259
Significance .681 .837 .891 .439 .102 .245
DIFF30 Correlation Coefficient .276 .256 −.118 −.037 .163 −.028
Significance .213 .250 .602 .870 .469 .903
LOGDIFF5 Correlation Coefficient .172 .056 .213 −.086 −.075 .030
Significance .444 .805 .340 .703 .739 .895
LOGDIFF10 Correlation Coefficient −.013 −.137 −.028 −.296 −.442* −.364
Significance .955 .552 .904 .192 .045 .105
LOGDIFF15 Correlation Coefficient −.040 −.156 −.120 −.307 −.534* −.448*
Significance .864 .500 .605 .176 .013 .042
LOGDIFF30 Correlation Coefficient .084 .079 −.127 −.187 −.100 −.211
Significance .726 .740 .592 .430 .673 .372
PERC5 Correlation Coefficient 0.000 −.105 .228 −.044 −.062 .013
Significance 1.000 .642 .308 .845 .783 .954
PERC10 Correlation Coefficient 0.000 −.129 .071 −.107 −.296 −.188
Significance 1.000 .568 .752 .636 .181 .402
PERC15 Correlation Coefficient −.034 −.186 .012 −.225 −.361 −.316
Significance .881 .408 .958 .315 .099 .152
PERC30 Correlation Coefficient .190 .179 −.119 .028 .252 −.003
Significance .396 .426 .596 .903 .258 .990
LOGPERC5 Correlation Coefficient 0.000 −.105 .228 −.044 −.062 .013
Significance 1.000 .642 .308 .845 .783 .954
LOGPERC10 Correlation Coefficient −.149 −.246 −.007 −.234 −.464* −.367
Significance .521 .282 .975 .308 .034 .102
LOGPERC15 Correlation Coefficient −.186 −.312 −.076 −.363 −.537* −.514*
Significance .420 .169 .745 .105 .012 .017
LOGPERC30 Correlation Coefficient −.019 −.017 −.114 −.096 .016 −.166
Significance .937 .942 .633 .688 .947 .485
Fluorophotometry values are categorized into 4 major schemes. 1) Increases in fluorescein concentration relative to its baseline at multiple time intervals (5, 10,
15, and 30 min) are labeled ‘DIFF X’ where X represents the minutes. 2) Log values of ‘DIFF X’ are labeled ‘LOGDIFF X.’ 3) Percent changes in fluorescein
concentration relative to its baseline at multiple time intervals (5, 10, 15, and 30 min) are labeled ‘PERC X.’ 4) Log values of ‘PERC X’ are labeled ‘LOGPERC X.’
Fluorophotometry scoring schemes are compared with Ocular Surface Disease Index (OSDI), tear break up time (TBUT), fluorescein, and lissamine. OSDI scores
were adjusted into quartiles (0–25 = score of 1, 26–50 = score of 2, 51–75 = score of 3, 76–100 = score of 4) and called ‘OSDI Quartiles.’ An aggregate score was
calculated by adding OSDI quartiles, TBUT, fluorescein, and lissamine
All significance (p-value) are two-tailed, and p < 0.05 was considered statistically significant. Correlation coefficients and significance are bolded with asterisks* if
less than 0.05
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even as patients report multitude of symptoms. With
fluorophotometry’s capability to differentiate dry eyes
from normal eyes, one possibility could be to use fluor-
ophotometry as one of DED screening tools to detect
subclinical DED in seemingly healthy patients. Earlier
detection could lead to earlier treatment, or possible
prevention of progression to severe DED when it may
be more difficult to intervene. Higher values of fluoro-
photometry in DED patients correlate with increased
permeability of the cornea, so fluorophotometry could
be used to measure progression of corneal damage and
assess whether current treatments for DED are suffi-
cient, adjusting as needed depending on the results [17].
This study is not without limitations. Sample size was
limited, and this factor most likely contributed to the
relatively high variability in fluorescein concentrations
with the fluorophotometer. More eyes may reduce this
variability, but the biggest likely cause of this variation
is the lumping of all DED eyes into one dry eye group.
Mild DED was not differentiated from severe DED, as
there was no clear way to do so without a gold standard
or correlations with other exams. The next step would
be to explore whether fluorophotometry correlates with
DED severity, especially if it may be a tool that can
grade DED severity on a sliding scale. Furthermore, we
cannot eliminate some of the intrinsic problems associ-
ated with fluorescein, especially at higher concentra-
tions, and the Fluorotron Master flurophotometer
itself. For instance, because the machine cannot clearly
distinguish the tear film from the cornea, we utilized a
similar washing method from previous studies to elim-
inate any excess fluorescein remaining in the tear film
and to standardize the technique [8, 12, 18, 19]. Al-
though the process was controlled as much as possible,
some patients may have more or less fluorescein left on
the tear film, possibly due to mechanical issues such as
excessive tearing or blinking. Finally, although we
aimed to capture most factors that contribute to DED,
not all possible diagnostic tests were done to reduce
burden on the patients. In future studies, comparing
fluorophotometry to more diagnostic tests such as tear
osmolarity may be beneficial.
Conclusions
The degree of ocular surface disease as measured by fluor-
ophotometry generally did not correlate with any other
clinical DED tests. Given fluorophotometry’s capability of
differentiating between DED and normal eyes, there may
be an aspect of DED that is missed in the current regimen
of DED tests and only captured with fluorophotometry.
Adding fluorophotometry as another diagnostic test for
DED may be useful in screening, assessing, and monitor-
ing patients with DED.
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